The enrichment in the signature associated with TGF-β activation and EMT demonstrated the activity of the tumor suppressor gene and, indirectly, that the nS/MAR technology can provide the sustained expression of functional SMAD4 throughout hundreds of cell divisions. This evidence concerns the gene TGFB1 and neoplasm.